Latest Articles
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) - GuruFocus
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) GuruFocus
Published: June 2, 2025, 7:05 p.m.
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal - MSN
OPINION - I’ve passed out, been hospitalised and still done my job — Bella Hadid is right, working on your period should be illegal MSN
Published: June 2, 2025, 6:50 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer - Medical Xpress
Adding immunotherapy to standard chemotherapy extends quality of life for patients with advanced endometrial cancer Medical Xpress
Published: June 2, 2025, 6:20 p.m.
Women to Watch: Elle Hinnah - Greenway Magazine
Women to Watch: Elle Hinnah Greenway Magazine
Published: June 2, 2025, 5:43 p.m.
CNN's Chief National Security Correspondent Alex Marquardt Exits Months After Defamation Lawsuit - TheWrap
CNN's Chief National Security Correspondent Alex Marquardt Exits Months After Defamation Lawsuit TheWrap
Published: June 2, 2025, 4:43 p.m.
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet - k99.com
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet k99.com
Published: June 2, 2025, 4:30 p.m.
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet - Duluth Country Radio
Bunnie Xo Considers Stopping IVF as She Endures Worst Side Effects Yet Duluth Country Radio
Published: June 2, 2025, 4:30 p.m.
Link copied to clipboard!